4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Chemomab Therapeutics Ltd. (CMMB) operates in the Biotechnology industry and is headquartered in Tel Aviv-Yafo, Israel. Its market capitalization is roughly $20 million. In the fiscal year ended 2025-12-31, CMMB reported $0M in revenue and ($9M) in net income.
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($10M) | ($15M) | ($26M) | ($28M) | — |
| Net Income | ($9M) | ($14M) | ($24M) | ($28M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $14M | $17M | $22M | $43M | — |
| Total Liabilities | $2M | $3M | $5M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CMMB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms